OGI News and Press, Organigram Holdings Inc. From 01/08/24

2024-01-08 00:03:36 ET Summary Assertio Holdings has dropped substantially and is down more than 70% in the past year. Assertio Holdings appears to have been oversold based on quantitative factors. It trades at a very low enterprise value to revenue ratio compared to its peers. ...

2024-01-05 17:35:59 ET Top Marijuana Stocks For People In The Cannabis Sector Marijuana stocks could soon see a recovery in the sector. With the start of the new year comes the chance for marijuana stocks to reach better trading levels. Especially with the ongoing fight to establish...

2023-12-31 11:55:21 ET Summary Organigram's Q4 results exceeded revenue expectations but had weaker than expected adjusted EBITDA. Analysts have lowered their projections for Organigram's revenue and adjusted EBITDA for FY24 and FY25. British American Tobacco (BAT) is buying a...

Special Meeting to Approve $124.6 Million Investment from BAT at $3.2203/share and Creation of “Jupiter” Strategic Investment Pool Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “ Company ” or “ Organigram ”), a leading licens...

2023-12-24 09:06:10 ET Summary Green Thumb Industries is a popular cannabis stock that has rallied 54% since July. GTI's revenue has increased by only 2% in 2023, but its operating cash flow has improved. Analysts expect GTI's revenue and adjusted EBITDA to increase in 2024 an...

2023-12-20 07:30:00 ET Summary Organigram reported FQ4'23 numbers highlighting structural problems in the Canadian cannabis market. The company's net revenue growth was only 1% due to high excise taxes and the additional push into new SKUs again resulted in minimal gross profits. ...

2023-12-19 15:15:16 ET Image source: The Motley Fool. Organigram (NASDAQ: OGI) Q4 2023 Earnings Call Dec 19, 2023 , 8:00 a.m. ET Operator Continue reading For further details see: Organigram (OGI) Q4 2023 Earnings Call Transcript

2023-12-19 11:47:10 ET Organigram Holdings Inc. (OGI) Q4 2023 Earnings Conference Call December 19, 2023, 08:00 AM ET Company Participants Max Schwartz - Director, IR Beena Goldenberg - CEO Tim Emberg - Chief Commercial Officer Paolo De Luca - Chief Strategy ...

2023-12-19 06:13:01 ET More on Organigram Holdings Organigram Is A Great Stock For Value Investors Organigram Holdings: Earnings Growth Set To Continue Organigram names Paolo De Luca interim CFO Biggest stock movers today: Paramount Global, Organigram, Cellde...

Domestic share growth in several key categories continues to be driven by innovation excellence and industry-leading R&D. Organigram continues to take a leadership position in industry fighting THC mislabelling (inflation). Company fortifying itself with recently announced BAT...